BioCentury
ARTICLE | Company News

HalioDx sales and marketing update

November 17, 2016 10:43 PM UTC

HalioDx launched the Immunoseek CR (CD8/PD-L1) to measure expression of PD-L1 on tumor and immune cells and the density of CD8+ T cells. The company said the multiplexed assay, which uses formalin-fi...